Ina Scherlitz-Hofmann

Title: The Innovative Contributions of Ina Scherlitz-Hofmann

Introduction

Ina Scherlitz-Hofmann is a notable inventor based in Falkensee, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor agents. With a total of 2 patents, her work has the potential to impact cancer treatment significantly.

Latest Patents

One of her latest patents is focused on antitumor-active 2-alkoxyestradiol sulfamates. This invention relates to the use of 2-alkoxyestrogen sulfamates characterized by a specific formula. The compounds are distinguished by their 2-alkoxy substitution in conjunction with the 17-hydroxy substitution. They exhibit a unique ability to inhibit tubulin polymerization, making them useful for treating prostate cancers. Another patent involves C13-substituted estra-1,3,5,(10)-trien-3-yl sulfamates, which includes methods of preparation and pharmaceutical compositions containing these compounds.

Career Highlights

Throughout her career, Ina has worked with prominent companies in the pharmaceutical industry, including Schering Aktiengesellschaft and Sterix Limited. Her experience in these organizations has contributed to her expertise in drug development and innovation.

Collaborations

Ina has collaborated with notable colleagues such as Sigfrid Schwarz and Olaf Peters. These partnerships have likely enhanced her research and development efforts in the pharmaceutical field.

Conclusion

Ina Scherlitz-Hofmann's innovative work in the development of antitumor agents showcases her significant contributions to cancer treatment. Her patents reflect her dedication to advancing medical science and improving patient outcomes.